logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

AYTU
Aytu BioPharma, Inc.
2.16
2 x 1.52
2 x 2.72
bid
ask
+
0.01
0.47%
2 @ 04:00 PM
2.16 +0.00 (0.00%)
Ytd-16.92%
1y-4.42%
2.12
day range
2.19
1.65
52 week range
3.07
Open2.12Prev Close2.15Low2.12High2.19Mkt Cap23.18M
Vol6.84KAvg Vol38.64KEPS-4.61P/EN/AForward P/E3.57
Beta-1.40Short Ratio10.45Inst. Own34.04%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-1450-d Avg2.29200-d Avg2.371yr Est8.00

AYTU News

benzinga.com
Aytu BioPharma And And Lannett Terminate Metadate Agreement Effective June 23, 2026; Co. To Continue

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001385818/000143774926021707/aytu20260624c_8k.htm

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session

benzinga.com
Ascendiant Capital Maintains Buy on Aytu BioPharma, Raises Price Target to $14.5

Ascendiant Capital analyst Edward Woo maintains Aytu BioPharma (NASDAQ:AYTU) with a Buy and raise